Last reviewed · How we verify
NCT04684004
Hyperglycemia in Patients With Takotsubo Syndrome
trial testing To report number of HF events and deaths in Takotsubo Cardiomyopathy in 40 participants. Completed in 1 January 2019.
1 January 2017
Quick facts
| Lead sponsor | University of Campania Luigi Vanvitelli |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 January 2013 |
| Primary completion | 1 January 2017 |
| Estimated completion | 1 January 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- To report number of HF events and deaths
Conditions studied
- Takotsubo Cardiomyopathy — all drugs for Takotsubo Cardiomyopathy →
Sponsor
University of Campania Luigi Vanvitelli
Who can join
Adults 18 to 75, any sex, with Takotsubo Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with Takotsubo cardiomiopathy (TTC) have over-inflammation and over-sympathetic tone. However, these conditions could cause higher rate of heart failure (HF) events and deaths at 2 years of follow-up. Conversely, hyperglycemia vs. normoglycemia could result in over expression of inflammatory markers and catecholamines thta could result in higher rate of HF and deaths at 2 years of follow-up in TTC patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04684004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Takotsubo Cardiomyopathy
Currently open trials in the same condition.
- NCT07491718 — Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy · NA · recruiting
- NCT06597331 — Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital · recruiting
- NCT05977049 — Psychosocial Support for Patients With Takotsubo Syndrome · NA · recruiting
- NCT06332859 — Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease · NA · recruiting
- NCT05793008 — Characterization of priMary And sEcondary STress Related takOtsubo · NA · recruiting
Other University of Campania Luigi Vanvitelli trials
Trials by the same sponsor.
- NCT07590349 — Personalized Robotic Telerehabilitation for Upper Limb Functional Recovery After Stroke in a Home-Based Setting · NA · not yet recruiting
- NCT06718452 — Tinnitus and Treatment With umPEA-LUT · NA · not yet recruiting
- NCT07124676 — Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to · not yet recruiting
- NCT07425912 — Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes · active not recruiting
- NCT06991816 — The Brain&Senses Study · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04684004 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Campania Luigi Vanvitelli
- Last refreshed: 28 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04684004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing